He is the Executive Officer for the Translational Research Program for The Alliance for Clinical Trials and directs the Imunohistochemistry C ore Laboratory for the Melanoma Moonshot Program at MD Anderson. Dr. Tetzlaff earned his medical degree from the University of Texas at Austin. He completed his residency in Anatomic Pathology in The Department of Pathology with fellowship in the Department of Dermatology at The Hospital of the University of Pennsylvania. Following his training, Dr. Tetzlaff began his academic career at MD Anderson. He serves on the Editorial Boards of Human Pathology, American Journal of Clinical Pathology and Applied Immunohistochemistry &Molecular Morphology. He is an author of over 100 published peer-reviewed manuscripts.